Evidence map›Paper›PMID 28303072›Full record

ReviewThe Clinical biochemist. Reviews2016

Achievements and Future Directions of the APFCB Mass Spectrometry Harmonisation Project on Serum Testosterone.

Ronda F Greaves, Chung S Ho, Kirsten E Hoad, John Joseph, Brett McWhinney, Janice P Gill, Therese Koal, Chris Fouracre, Heidi P Iu, Brian R Cooke and 3 more

Abstract readReview
In one paragraph

Review in The Clinical biochemist. Reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ronda F GreavesSchool of Health and Biomedical Sciences, RMIT University, Victoria, Australia; Murdoch Children's Research Institute, Victoria, Australia.
Chung S HoPrince of Wales Hospital, Shatin, Hong Kong SAR.
Kirsten E HoadPathWest Laboratory Medicine Fiona Stanley Hospital, Western Australia, Australia.
John JosephQueen Elizabeth II Hospital, Perth, Western Australia, Australia.
Brett McWhinneyPathology Queensland, Brisbane, Queensland, Australia.
Janice P GillRCPAQAP Chemical Pathology, Adelaide, South Australia, Australia.
Therese KoalBiocrates Life Sciences AG, Innsbruck, Austria.
Chris FouracreAgilent Technologies, Sydney, NSW, Australia.
Heidi P IuQueen Elizabeth Hospital, Kowloon, Hong Kong SAR.
Brian R CookePathWest Laboratory Medicine Fiona Stanley Hospital, Western Australia, Australia.
Conchita BoyderQueen Elizabeth II Hospital, Perth, Western Australia, Australia.
Hai T PhamBiocrates Life Sciences AG, Innsbruck, Austria.
Lisa M JollyRCPAQAP Chemical Pathology, Adelaide, South Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As an outcome of the 2010 Asian Pacific Conference for Chromatography and Mass Spectrometry in Hong Kong, a collaborative working group was formed to promote the harmonisation of mass spectrometry methods. The Mass Spectrometry Harmonisation Working Group resides under the combined auspices of the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) and the Australasian Association of Clinical Biochemists (AACB). A decision was made to initially focus attention on serum steroids due to the common interest of members in this area; with the first steroid to assess being testosterone. In principle, full standardisation with traceability should be achievable for all steroids as they are small compounds with defined molecular weight and structure. In order to achieve this we need certified reference materials, reference methods, reference laboratories, reference intervals and external quality assurance programs; each being an important pillar in the process. When all the pillars are present, such as for serum testosterone, it is feasible to fully standardise the liquid chromatography - tandem mass spectrometry (LC-MS/MS) methods. In a collaborative process with interested stakeholders, we commenced on a pathway to provide ongoing assessment and seek opportunities for improvement in the LC-MS/MS methods for serum steroids. Here we discuss the outcomes to date and major challenges related to the accurate measurement of serum steroids with a focus on serum testosterone.

Identifiers

PMID28303072
PMCPMC5198509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.